Insider Buying: OneMedNet (NASDAQ:ONMD) Director Buys 129,758 Shares of Company Stock

OneMedNet Corporation (NASDAQ:ONMD) Director Thomas Kosasa purchased 129,758 shares of the company’s stock in a transaction that occurred on Wednesday, October 7th. The shares were purchased at an average price of $5.78 per share, for a total transaction of $750,001.24. Following the transaction, the director owned 1,983,573 shares of the company’s stock, valued at $11,465,051.94. This trade represents a 7.00% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Thomas Kosasa also recently made the following trade(s):

• On Thursday, July 30th, Thomas Kosasa acquired 144,927 shares of OneMedNet stock. The stock was acquired at an average price of $6.90 per share, with a total value of $999,996.30.

OneMedNet Stock Up 2.3%

Shares of ONMD stock traded up $0.09 on Tuesday, reaching $4.02. 37,062 shares of the company were exchanged, compared to its average volume of 70,608. The business has a 50-day moving average price of $6.10 and a 200 day moving average price of $7.25. OneMedNet Corporation has a 1 year low of $3.61 and a 1 year high of $32.00.

Wall Street Analyst Weigh In

Separately, Weiss Ratings raised OneMedNet from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday, August 24th. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat, OneMedNet has an average rating of “Sell”.

OneMedNet Company Profile

OneMedNet Corporation is a healthcare technology company that develops infrastructure for accessing, managing and analyzing medical data. Its platform is designed to help healthcare providers, researchers, life sciences companies and other authorized users work with clinical and medical-imaging information while keeping the underlying data within the organization that controls it.

The company’s technology uses a federated data model, allowing participating institutions to collaborate on data analysis without routinely transferring sensitive patient information to a centralized repository.